John Thomas O'Malley, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mycosis Fungoides | 4 | 2023 | 162 | 1.100 |
Why?
|
| Dermatitis, Atopic | 8 | 2023 | 644 | 1.020 |
Why?
|
| STAT4 Transcription Factor | 6 | 2009 | 96 | 0.950 |
Why?
|
| Prurigo | 1 | 2023 | 21 | 0.900 |
Why?
|
| Lymphoma, T-Cell, Cutaneous | 3 | 2019 | 206 | 0.750 |
Why?
|
| Skin | 11 | 2022 | 4324 | 0.740 |
Why?
|
| Histiocytosis, Non-Langerhans-Cell | 1 | 2018 | 20 | 0.650 |
Why?
|
| T-Lymphocyte Subsets | 4 | 2022 | 1834 | 0.600 |
Why?
|
| Dermatitis | 1 | 2019 | 195 | 0.580 |
Why?
|
| Heavy Chain Disease | 1 | 2014 | 19 | 0.510 |
Why?
|
| Elastic Tissue | 1 | 2014 | 65 | 0.500 |
Why?
|
| Cutis Laxa | 1 | 2014 | 29 | 0.500 |
Why?
|
| Congresses as Topic | 1 | 2019 | 762 | 0.480 |
Why?
|
| Arthralgia | 1 | 2018 | 457 | 0.470 |
Why?
|
| Th1 Cells | 4 | 2016 | 1055 | 0.440 |
Why?
|
| Radiotherapy | 1 | 2019 | 1524 | 0.430 |
Why?
|
| Hyperpigmentation | 1 | 2013 | 109 | 0.400 |
Why?
|
| Skin Pigmentation | 1 | 2013 | 281 | 0.380 |
Why?
|
| Skin Neoplasms | 6 | 2023 | 5632 | 0.360 |
Why?
|
| Immunologic Memory | 4 | 2022 | 1348 | 0.340 |
Why?
|
| Severity of Illness Index | 10 | 2023 | 15510 | 0.280 |
Why?
|
| Health Status | 1 | 2019 | 4013 | 0.260 |
Why?
|
| Injections, Subcutaneous | 2 | 2023 | 664 | 0.250 |
Why?
|
| Interleukin-17 | 6 | 2020 | 894 | 0.230 |
Why?
|
| Skin Diseases | 3 | 2020 | 1064 | 0.210 |
Why?
|
| Double-Blind Method | 7 | 2023 | 11985 | 0.200 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2019 | 9124 | 0.200 |
Why?
|
| Th17 Cells | 2 | 2017 | 760 | 0.190 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 2 | 2019 | 339 | 0.180 |
Why?
|
| Pruritus | 1 | 2023 | 352 | 0.180 |
Why?
|
| Interleukin-12 | 4 | 2009 | 578 | 0.180 |
Why?
|
| T-Lymphocytes, Regulatory | 3 | 2016 | 2985 | 0.180 |
Why?
|
| Inflammation Mediators | 1 | 2008 | 1889 | 0.170 |
Why?
|
| CD8-Positive T-Lymphocytes | 4 | 2023 | 4424 | 0.170 |
Why?
|
| Eczema | 1 | 2021 | 225 | 0.170 |
Why?
|
| Dermatologic Agents | 1 | 2022 | 274 | 0.170 |
Why?
|
| Genes, T-Cell Receptor beta | 1 | 2018 | 72 | 0.160 |
Why?
|
| STAT3 Transcription Factor | 2 | 2016 | 875 | 0.160 |
Why?
|
| Monitoring, Immunologic | 1 | 2018 | 100 | 0.150 |
Why?
|
| Lymphomatoid Papulosis | 1 | 2017 | 16 | 0.150 |
Why?
|
| STAT6 Transcription Factor | 2 | 2007 | 199 | 0.150 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2018 | 3583 | 0.140 |
Why?
|
| Interleukin-9 | 1 | 2016 | 63 | 0.130 |
Why?
|
| Lymphoma, Large-Cell, Anaplastic | 1 | 2017 | 163 | 0.130 |
Why?
|
| STAT5 Transcription Factor | 1 | 2016 | 262 | 0.130 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2017 | 402 | 0.130 |
Why?
|
| Treatment Outcome | 10 | 2023 | 62691 | 0.130 |
Why?
|
| Candidiasis | 1 | 2017 | 365 | 0.130 |
Why?
|
| Candida albicans | 1 | 2017 | 392 | 0.120 |
Why?
|
| T-Lymphocytes | 4 | 2020 | 10140 | 0.120 |
Why?
|
| Interferon-gamma | 4 | 2020 | 3193 | 0.120 |
Why?
|
| Stevens-Johnson Syndrome | 1 | 2017 | 278 | 0.120 |
Why?
|
| Interferon Regulatory Factors | 1 | 2016 | 269 | 0.120 |
Why?
|
| Deafness | 1 | 2018 | 461 | 0.120 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2008 | 2397 | 0.120 |
Why?
|
| Nerve Degeneration | 1 | 2018 | 759 | 0.120 |
Why?
|
| Myeloproliferative Disorders | 1 | 2020 | 601 | 0.120 |
Why?
|
| Cytokines | 1 | 2008 | 7296 | 0.110 |
Why?
|
| Facial Transplantation | 1 | 2016 | 226 | 0.110 |
Why?
|
| Internationality | 1 | 2019 | 1004 | 0.110 |
Why?
|
| Psoriasis | 2 | 2017 | 888 | 0.110 |
Why?
|
| Arthritis | 1 | 2018 | 657 | 0.110 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2018 | 767 | 0.100 |
Why?
|
| Cochlea | 1 | 2018 | 830 | 0.100 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2020 | 1833 | 0.100 |
Why?
|
| Microscopy, Electron | 1 | 2014 | 2665 | 0.100 |
Why?
|
| Forkhead Transcription Factors | 2 | 2009 | 1603 | 0.100 |
Why?
|
| Humans | 31 | 2023 | 739219 | 0.090 |
Why?
|
| Influenza Vaccines | 1 | 2017 | 740 | 0.090 |
Why?
|
| Mice, SCID | 2 | 2020 | 2714 | 0.090 |
Why?
|
| Neoplasms, Second Primary | 1 | 2017 | 1045 | 0.080 |
Why?
|
| Dendritic Cells | 1 | 2020 | 2728 | 0.080 |
Why?
|
| Adult | 11 | 2023 | 213375 | 0.080 |
Why?
|
| Immunoglobulin A | 2 | 2022 | 989 | 0.080 |
Why?
|
| Cells, Cultured | 4 | 2017 | 19223 | 0.080 |
Why?
|
| Lipid Metabolism | 1 | 2017 | 1886 | 0.080 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2009 | 643 | 0.080 |
Why?
|
| Chronic Disease | 1 | 2023 | 9132 | 0.080 |
Why?
|
| Mice | 13 | 2022 | 80995 | 0.080 |
Why?
|
| Survival Rate | 2 | 2019 | 12760 | 0.080 |
Why?
|
| Graft vs Host Disease | 1 | 2020 | 2948 | 0.080 |
Why?
|
| Lymphocyte Transfusion | 1 | 2008 | 234 | 0.080 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2009 | 274 | 0.080 |
Why?
|
| Female | 15 | 2023 | 378808 | 0.080 |
Why?
|
| Sequence Deletion | 2 | 2008 | 1526 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 5 | 2017 | 21859 | 0.070 |
Why?
|
| Biopsy | 2 | 2020 | 6722 | 0.070 |
Why?
|
| Protein Isoforms | 2 | 2008 | 1725 | 0.070 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2012 | 543 | 0.070 |
Why?
|
| Immunity, Innate | 1 | 2019 | 2950 | 0.070 |
Why?
|
| HIV Infections | 1 | 2013 | 16763 | 0.070 |
Why?
|
| Influenza, Human | 1 | 2017 | 1476 | 0.070 |
Why?
|
| Diagnosis, Differential | 2 | 2020 | 12945 | 0.070 |
Why?
|
| Middle Aged | 8 | 2019 | 212833 | 0.070 |
Why?
|
| Boston | 1 | 2019 | 9314 | 0.070 |
Why?
|
| Graft Survival | 1 | 2016 | 3724 | 0.070 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2016 | 2843 | 0.070 |
Why?
|
| Lymphocyte Activation | 3 | 2016 | 5521 | 0.060 |
Why?
|
| Virion | 1 | 2007 | 435 | 0.060 |
Why?
|
| Lower Extremity | 1 | 2013 | 1145 | 0.060 |
Why?
|
| Male | 13 | 2023 | 348967 | 0.060 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2017 | 2518 | 0.060 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2007 | 525 | 0.060 |
Why?
|
| DNA, Complementary | 1 | 2007 | 2049 | 0.060 |
Why?
|
| Protein Engineering | 1 | 2007 | 543 | 0.060 |
Why?
|
| Cell Lineage | 2 | 2009 | 2498 | 0.060 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2008 | 831 | 0.060 |
Why?
|
| Animals | 13 | 2022 | 168358 | 0.050 |
Why?
|
| Graft Rejection | 1 | 2016 | 4379 | 0.050 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2020 | 5404 | 0.050 |
Why?
|
| Transcriptional Activation | 1 | 2008 | 1781 | 0.050 |
Why?
|
| Adolescent | 5 | 2022 | 85409 | 0.050 |
Why?
|
| Germany | 1 | 2023 | 853 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 1 | 2008 | 3849 | 0.050 |
Why?
|
| Prospective Studies | 3 | 2020 | 53036 | 0.050 |
Why?
|
| Gene Regulatory Networks | 1 | 2009 | 1708 | 0.050 |
Why?
|
| Gene Expression Regulation | 2 | 2009 | 12064 | 0.050 |
Why?
|
| Disease Susceptibility | 1 | 2007 | 1778 | 0.050 |
Why?
|
| Antineoplastic Agents | 1 | 2023 | 13622 | 0.050 |
Why?
|
| Phototherapy | 1 | 2023 | 372 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 1 | 2009 | 6391 | 0.050 |
Why?
|
| Hepacivirus | 1 | 2007 | 1371 | 0.040 |
Why?
|
| Cell Differentiation | 3 | 2017 | 11471 | 0.040 |
Why?
|
| Aged, 80 and over | 3 | 2019 | 57639 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2008 | 4205 | 0.040 |
Why?
|
| Mice, Transgenic | 2 | 2008 | 9738 | 0.040 |
Why?
|
| Administration, Topical | 1 | 2020 | 687 | 0.040 |
Why?
|
| Presbycusis | 1 | 2018 | 42 | 0.040 |
Why?
|
| Foreskin | 1 | 2018 | 31 | 0.040 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 2018 | 143 | 0.040 |
Why?
|
| Hearing Tests | 1 | 2018 | 122 | 0.040 |
Why?
|
| Influenza B virus | 1 | 2017 | 49 | 0.040 |
Why?
|
| Laboratories | 1 | 2021 | 457 | 0.040 |
Why?
|
| Immunocompetence | 1 | 2017 | 136 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2007 | 6609 | 0.040 |
Why?
|
| Weight Loss | 1 | 2008 | 2588 | 0.040 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 1 | 2018 | 249 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2008 | 4400 | 0.040 |
Why?
|
| Auditory Threshold | 1 | 2018 | 364 | 0.040 |
Why?
|
| Antigen-Presenting Cells | 1 | 2020 | 969 | 0.040 |
Why?
|
| Hair Cells, Auditory, Inner | 1 | 2018 | 191 | 0.040 |
Why?
|
| Vaccinia | 1 | 2017 | 76 | 0.040 |
Why?
|
| Mice, Knockout | 2 | 2008 | 14555 | 0.040 |
Why?
|
| Interleukin-23 | 2 | 2008 | 190 | 0.040 |
Why?
|
| Noise | 1 | 2018 | 278 | 0.030 |
Why?
|
| Cell Survival | 2 | 2017 | 5873 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2020 | 1866 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2017 | 18002 | 0.030 |
Why?
|
| China | 1 | 2021 | 2223 | 0.030 |
Why?
|
| Vaccinia virus | 1 | 2017 | 342 | 0.030 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2017 | 300 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2020 | 1958 | 0.030 |
Why?
|
| Clone Cells | 1 | 2018 | 1690 | 0.030 |
Why?
|
| Pharmaceutical Preparations | 1 | 2022 | 1066 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2017 | 805 | 0.030 |
Why?
|
| Multiple Sclerosis | 1 | 2008 | 3065 | 0.030 |
Why?
|
| Kidney Function Tests | 1 | 2016 | 681 | 0.030 |
Why?
|
| Lymphocyte Count | 1 | 2016 | 791 | 0.030 |
Why?
|
| Prognosis | 3 | 2020 | 28901 | 0.030 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2017 | 646 | 0.030 |
Why?
|
| Young Adult | 1 | 2019 | 56252 | 0.030 |
Why?
|
| Child | 4 | 2022 | 77029 | 0.030 |
Why?
|
| Glucocorticoids | 1 | 2022 | 2100 | 0.030 |
Why?
|
| Adaptive Immunity | 1 | 2017 | 709 | 0.030 |
Why?
|
| Age Distribution | 1 | 2018 | 2903 | 0.030 |
Why?
|
| Biological Transport | 1 | 2017 | 2117 | 0.030 |
Why?
|
| Aged | 3 | 2019 | 162667 | 0.030 |
Why?
|
| Amino Acid Sequence | 2 | 2017 | 13815 | 0.030 |
Why?
|
| Whole-Body Irradiation | 1 | 2012 | 449 | 0.030 |
Why?
|
| Kidney | 1 | 2007 | 7141 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2017 | 2181 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2019 | 76632 | 0.020 |
Why?
|
| Anemia, Aplastic | 1 | 2012 | 226 | 0.020 |
Why?
|
| Gene Expression | 1 | 2023 | 7789 | 0.020 |
Why?
|
| Disease Management | 1 | 2020 | 2448 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2016 | 1821 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2016 | 2184 | 0.020 |
Why?
|
| Infant, Newborn | 2 | 2018 | 25470 | 0.020 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 2275 | 0.020 |
Why?
|
| Splenomegaly | 1 | 2007 | 190 | 0.020 |
Why?
|
| Hemagglutinins | 1 | 2007 | 117 | 0.020 |
Why?
|
| RNA Interference | 1 | 2016 | 2894 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2016 | 3500 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2023 | 9259 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2017 | 6870 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2018 | 3453 | 0.020 |
Why?
|
| Base Sequence | 1 | 2017 | 12807 | 0.020 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2007 | 310 | 0.020 |
Why?
|
| Interleukin-18 | 1 | 2007 | 248 | 0.020 |
Why?
|
| Cell Movement | 1 | 2017 | 5220 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2017 | 2971 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2017 | 3693 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2018 | 12235 | 0.020 |
Why?
|
| Inflammation | 2 | 2018 | 10531 | 0.020 |
Why?
|
| Bone Marrow Transplantation | 1 | 2012 | 2760 | 0.020 |
Why?
|
| Interleukin-10 | 1 | 2008 | 1199 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 8395 | 0.010 |
Why?
|
| Antigens | 1 | 2007 | 1462 | 0.010 |
Why?
|
| Spleen | 1 | 2007 | 2358 | 0.010 |
Why?
|
| Glycoproteins | 1 | 2008 | 2259 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2016 | 10446 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2017 | 21691 | 0.010 |
Why?
|
| Risk Factors | 2 | 2017 | 71972 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2016 | 16624 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2020 | 40385 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2007 | 3421 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2007 | 3194 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2008 | 5073 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2017 | 40801 | 0.010 |
Why?
|
| United States | 1 | 2022 | 69568 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2016 | 38941 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2009 | 13006 | 0.010 |
Why?
|
| Cell Line | 1 | 2007 | 15982 | 0.010 |
Why?
|
| Time Factors | 1 | 2009 | 40040 | 0.000 |
Why?
|